These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
330 related articles for article (PubMed ID: 11883361)
21. Sequential screening for trisomy 21 by nuchal translucency measurement in the first trimester and maternal serum biochemistry in the second trimester in a low-risk population. Schuchter K; Hafner E; Stangl G; Ogris E; Philipp K Ultrasound Obstet Gynecol; 2001 Jul; 18(1):23-5. PubMed ID: 11489220 [TBL] [Abstract][Full Text] [Related]
22. Pregnancy outcomes with increased nuchal translucency after routine Down syndrome screening. Cheng CC; Bahado-Singh RO; Chen SC; Tsai MS Int J Gynaecol Obstet; 2004 Jan; 84(1):5-9. PubMed ID: 14698823 [TBL] [Abstract][Full Text] [Related]
23. Re: outcome of pregnancy in chromosomally normal fetuses with increased nuchal translucency in the first trimester. Yagel S; Imbar T; Valsky DV Ultrasound Obstet Gynecol; 2002 Apr; 19(4):417-21. PubMed ID: 11952979 [No Abstract] [Full Text] [Related]
24. Absence of fetal nasal bone and aneuploidies at first-trimester nuchal translucency screening in unselected pregnancies. Zoppi MA; Ibba RM; Axiana C; Floris M; Manca F; Monni G Prenat Diagn; 2003 Jun; 23(6):496-500. PubMed ID: 12813765 [TBL] [Abstract][Full Text] [Related]
25. Measurement of nuchal translucency as a single strategy in trisomy 21 screening: should we use any other marker? Comas C; Torrents M; Muñoz A; Antolín E; Figueras F; Echevarría M Obstet Gynecol; 2002 Oct; 100(4):648-54. PubMed ID: 12383528 [TBL] [Abstract][Full Text] [Related]
26. [Ultrasound screening for Down syndrome and other chromosomal abnormalities by fetal nuchal translucency measurement between 11-14 weeks of gestation]. Dimitrova V; Markov D; Chernev T; Karag'ozova Zh; Mazneĭkova V; Andonova S; Vŭzharova R Akush Ginekol (Sofiia); 2005; 44(1):32-7. PubMed ID: 15853009 [TBL] [Abstract][Full Text] [Related]
27. [Pregnancy outcome in fetuses with increased nuchal translucency thickness at 10-14 weeks of pregnancy]. Maymon R; Dreazen E; Tovbin Y; Weinraub Z; Herman A Harefuah; 1999 Jun; 136(11):851-5, 916, 915. PubMed ID: 10955127 [TBL] [Abstract][Full Text] [Related]
28. Outcome of chromosomally normal livebirths with increased fetal nuchal translucency at 10-14 weeks' gestation. Brady AF; Pandya PP; Yuksel B; Greenough A; Patton MA; Nicolaides KH J Med Genet; 1998 Mar; 35(3):222-4. PubMed ID: 9541107 [TBL] [Abstract][Full Text] [Related]
34. Ultrasonographic markers for chromosomal abnormalities in women with negative nuchal translucency and second trimester maternal serum biochemistry. Verdin SM; Whitlow BJ; Lazanakis M; Kadir RA; Chatzipapas I; Economides DL Ultrasound Obstet Gynecol; 2000 Oct; 16(5):402-6. PubMed ID: 11169322 [TBL] [Abstract][Full Text] [Related]
35. [Screening for aneuploidy by first trimester nuchal translucency measurement: results from a prospective trial including 1980 cases in a single center in Switzerland]. Tercanli S; Holzgreve W; Batukan C; Gerber A; Ermis H; Miny P Ultraschall Med; 2002 Feb; 23(1):22-6. PubMed ID: 11842368 [TBL] [Abstract][Full Text] [Related]
36. The effect of nuchal translucency measurement on second-trimester biochemical screening for Down's syndrome. Kadir RA; Economides DL Ultrasound Obstet Gynecol; 1997 Apr; 9(4):244-7. PubMed ID: 9168574 [TBL] [Abstract][Full Text] [Related]
37. [Screening for Down's syndrome at week 10-14 by measuring fetal nuchal translucency thickness]. Maymon R; Dreazen E; Weinraub Z; Bukovsky I; Herman A Harefuah; 1999 Nov; 137(9):353-7, 432. PubMed ID: 11419032 [TBL] [Abstract][Full Text] [Related]